Excellent thought provokers. I address a couple.

Chicago - A minority shareholder takeover, ie., HEPA, et.al.?

Chicago - A slow drift to China? (lower shareprice, HEPA ownership)

I did a rough calculation if the 5 day rolling average weighted share price stays at about $0.60 cdn. Hepa can start converting their $6mm USD debenture into shares at the last 5 day weighted rolling avaerage share price. If they did this and then converted their existing warrants (11,466,619) they would hold roughly 41.3% of RVX stock.

Then, since Don and his team turned down a BP with their 5 year BoM2 trial at $200,000,000 USD trial cost in favour of their $70,000,000 2.5 year (probably underpowered   :) ) trial that he has yet to announce the funding source. Suppose Hepa is the only party to come forward. That could put them well above 50% ownership of RVX if the funded $70,000,000 USD at $.70/share cdn.

I'm not the brightest light in the Christmas tree but I think my calculations are close. I'm sure I'll be corrected if not.

If the Covid trial ever starts and it is a success this, of course, will change the game, but probably not management.

Chicago - A rudderless endeavor?

Me - Sure seems like it.

But the science seems excellent and I'm in for sure. Who knows but a rabbit could be pulled out of hat at any minute.

GLTA

Toinv